MSD

News

Lung cancer drug Keytruda to become routinely available on N...

NICE has given the green light for lung cancer drug Keytruda to be used as a routine treatment for certain patients in England.

News

Despite ‘no pick and mix’ warning, pharma’s Brexit planners ...

The chairman of a pan-European pharma group says he is still optimistic that a Brexit deal can be struck, despite the head of the European Council rejecting British plans for future alignment.

News

MSD attracts top British scientist to head up UK discovery c...

Dr Fiona Marshall joins MSD from Sosei from Heptares, the UK biotech company she co-founded more than a decade ago, and which was acquired by Sosei in 2015.

Healthcare

MSD and Wayra to fund UK digital health start-ups

Big pharma company Merck Sharp & Dohme is teaming up with Wayra UK to offer more start-up funds for new digital health companies in the UK.

News

NHS must drive forward life sciences strategy, says Lords' l...

Big pharma investment "very important", says peer.

News

Will the NHS force doctors to prescribe biosimilars?

NHS authorities could begin to use the reimbursement system as a “stick” to ensure doctors prescribe cheaper biosimilar medicines amid varied uptake in different regions.

Lung cancer drug Keytruda to become routinely available on N...

Despite ‘no pick and mix’ warning, pharma’s Brexit planners ...

MSD attracts top British scientist to head up UK discovery c...

MSD and Wayra to fund UK digital health start-ups

NHS must drive forward life sciences strategy, says Lords' l...

Will the NHS force doctors to prescribe biosimilars?

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

MSD

Editor's Picks